Sharon Shacham, Chief Scientific Officer at Karyopharm Therapeutics Inc. (KPTI), sold 12,452 shares at $10.24 ($128K) on 2022-02-28, disclosed to the SEC on 2022-03-02.
Open-market sale of $128k KPTI by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.24 | 6,226 | $64K | 50.0% |
| 2 | $10.24 | 6,226 | $64K | 50.0% |
| Total | $10.24 avg | 12,452 | $128K | 100% |
| Filing → |
| KPTI | SELL | 2021-03-23 | $50K | — | Filing → |
| KPTI | SELL | 2021-02-22 | $282K | — | Filing → |
| KPTI | SELL | 2021-02-17 | $411K | — | Filing → |